Synthesis of MMP inhibitor radiotracer [11C]CGS 25966, a new potential PET tumor imaging agent

22Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

[11C]CGS 25966, a novel radiolabeled matrix metalloproteinase (MMP) inhibitor, has been synthesized for evaluation as new potential positron emission tomography (PET) tumor imaging agent. The precursor was labeled by [11C]methyl triflate through O-[11C]methylation method at the hydroxyl position of phenol under basic conditions and isolated by HPLC purification to produce pure target compound in 15-25% radiochemical yield, based on 11CO2, decay corrected to end of bombardment. Copyright © 2003 John Wiley & Sons, Ltd.

Cite

CITATION STYLE

APA

Fei, X., Zheng, Q. H., Liu, X., Wang, J. Q., Stone, K. L., Miller, K. D., … Hutchins, G. D. (2003). Synthesis of MMP inhibitor radiotracer [11C]CGS 25966, a new potential PET tumor imaging agent. Journal of Labelled Compounds and Radiopharmaceuticals, 46(4), 343–351. https://doi.org/10.1002/jlcr.675

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free